nejm semaglutide ckd Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Long-Term Effects of Empagliflozin in

High frequency of lactase activity deficiency in small bowel of adults in the Neapolitan rea

While glucagon-like peptide-1 receptor modulators (GLP-1 RMs) are established therapies for obesity, their role in the management of dumping syndrome remains unclear

Support groups can be a very personal experience when you can make some much-needed connections with fellow members of the OCD community

UK regulatory guidance is that strong personal-outcome timelines for an unlicensed substance fall inside the medicinal-claim definition under the Human Medicines Regulations 2012

P.SchwerdtleT.SchulzeM

Front Public Health 13:1585711